• 2022-09-26
    Last Updated
  • 200
    Pages

Bispecific Antibody Market - Forecast(2022 - 2030)

DESCRIPTION
TABLE OF CONTENT

marketreports.info delivers well-researched industry-wide information on the Bispecific Antibody market. It provides information on the market’s essential aspects such as top participants, factors driving Bispecific Antibody market growth, precise estimation of the Bispecific Antibody market size, upcoming trends, changes in consumer behavioral pattern, market’s competitive landscape by Ablynx (Belgium), Adimab (United States), Affimed Therapeutics (Germany), Amgen (United States), AstraZeneca (MedImmune) (United States), Chugai Pharmaceutical (Japan), Eli Lilly (United States), EMD Serono (United States), Neovii Biotech (Germany), NovImmune SA (Switzerland), Roche (Switzerland), Sanofi (France), Emergent BioSolutions (United States), Genentech (United States), MacroGenics (United States), Merus (Netherlands), key market vendors, and other market features to gain an in-depth analysis of the Bispecific Antibody market. Additionally, the report is a compilation of both qualitative and quantitative assessment by industry experts, as well as industry participants across the value chain. The Bispecific Antibody report also focuses on the latest developments that can enhance the performance of various market segments into Bispecific Antibody verticales .

The Bispecific Antibody research report provides deep insights into the global market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per Bispecific Antibody market segment. The Bispecific Antibody report provides an overview of the growth rate of Bispecific Antibody market during the forecast period, i.e., 2022–2030. Most importantly, the Bispecific Antibody report further identifies the qualitative impact of various market factors on market segments and geographies. The Bispecific Antibody research segments the market on the basis of product type, application, technology, and region. To offer more clarity regarding the Bispecific Antibody industry, the report takes a closer look at the current status of various factors including but not limited to supply chain management, niche markets, distribution channel, trade, supply, and demand and production capability across different countries.

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

Note – The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain including Bispecific Antibody industry. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries inclduing Bispecific Antibody. This report on Bispecific Antibody provides the analysis on impact on Covid-19 on various business segments and country markets. The reports also showcase market trends and forecast to 2030, factoring the impact of Covid -19 Situation in the Bispecific Antibody industy.

The scope of the Report:

The report segments the global Bispecific Antibody Market based on application, type, service, technology, and region. Each chapter under Bispecific Antibody segmentation allows readers to grasp the nitty-gritty of the market. A magnified look at the segment-based analysis is aimed at giving the readers a closer look at the opportunities and threats in the Bispecific Antibody market. It also addresses political scenarios that are expected to impact the Bispecific Antibody market in both small and big ways. The report on the global Bispecific Antibody Market examines changing regulatory scenarios to make accurate projections about potential investments. It also evaluates the risk for new entrants and the intensity of the competitive rivalry.

Major highlights of the report:

  • All-inclusive evaluation of the Bispecific Antibody market
  • Evolution of significant Bispecific Antibody market aspects
  • Industry-wide investigation of Bispecific Antibody market segments
  • Assessment of Bispecific Antibody market value and volume in past, present, and forecast years
  • Evaluation of Bispecific Antibody market share
  • Tactical approaches of Bispecific Antibody market leaders
  • Lucrative strategies to help companies strengthen their position in the Bispecific Antibody market

Major key players covered in this Bispecific Antibody report:

Ablynx (Belgium), Adimab (United States), Affimed Therapeutics (Germany), Amgen (United States), AstraZeneca (MedImmune) (United States), Chugai Pharmaceutical (Japan), Eli Lilly (United States), EMD Serono (United States), Neovii Biotech (Germany), NovImmune SA (Switzerland), Roche (Switzerland), Sanofi (France), Emergent BioSolutions (United States), Genentech (United States), MacroGenics (United States), Merus (Netherlands)

By Application
Diagnosis of Bacterial Infections
Diagnosis of Viral Infections
BsMAb for Cancer Diagnostic
BsAbs Blocking Signaling Pathways
BsAbs Targeting Tumor Angiogenesis
By Design
Bispecific Diabodies
Bispecific T-Cell Engager Antibodies (BiTEs)

By Mechanism of Action
Trifunctional Antibody (Catumaxomab)
Blinatumomab

Bispecific Antibody Market Segmented by Region/Country: North America, Europe, Asia Pacific, Middle East & Africa, and Central & South America

Reason to Buy

  • Save and reduce time carrying out entry-level Bispecific Antibody research by identifying the growth, size, leading players and segments in the global Bispecific Antibody market.
  • Highlights key business priorities in order to guide the top Bispecific Antibody companies to reform their business strategies and establish themselves in the wide geography.
  • The key findings and recommendations highlight crucial progressive industry trends in the Bispecific Antibody market, thereby allowing players to develop effective long term strategies in order to garner their Bispecific Antibody market revenue. 
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging Bispecific Antibody markets.
  • Scrutinize in-depth global market Bispecific Antibody trends and outlook coupled with the factors driving the market, as well as those restraining the growth at a certain extent.

Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry Bispecific Antibody verticals.

Thanks for reading this release; you can also customize this report to get select chapters or region-wise coverage with regions such as Asia, North America, and Europe for Bispecific Antibody Market.

Chapter 1 Global Bispecific Antibody Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Bispecific Antibody Market
1.4 Restraints for Bispecific Antibody Market
1.5 Opportunities for Bispecific Antibody Market
1.6 Trends for Bispecific Antibody Market
1.7 COVID-19 Impact Assessment on Bispecific Antibody Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Bispecific Antibody Market Overview

2.1 Global Bispecific Antibody Market by Product Type
2.1.1 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Bispecific Antibody Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Bispecific Antibody Market by End User
2.2.1 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Bispecific Antibody Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Bispecific Antibody Market by Region
2.3.1 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Bispecific Antibody Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Bispecific Antibody Market Outlook (2013-2029)
2.4.1 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Bispecific Antibody Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Bispecific Antibody Market Y-o-Y Growth Rate by Region
2.8.2 Global Bispecific Antibody Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Bispecific Antibody Market Y-o-Y Growth Rate by End User
2.9 Global Bispecific Antibody Market Share Comparison (2013-2029)
2.9.1 Global Bispecific Antibody Market Share by Region
2.9.2 Global Bispecific Antibody Market Share by Product Type
2.9.3 Global Bispecific Antibody Market Share by End User

Chapter 3 North America Bispecific Antibody Market Overview

3.1 North America Bispecific Antibody Market by Product Type
3.1.1 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Bispecific Antibody Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Bispecific Antibody Market by End User
3.2.1 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Bispecific Antibody Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Bispecific Antibody Market by Region
3.3.1 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Bispecific Antibody Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Bispecific Antibody Market Outlook (2013-2029)
3.4.1 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Bispecific Antibody Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Bispecific Antibody Market Y-o-Y Growth Rate by Region
3.8.2 North America Bispecific Antibody Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Bispecific Antibody Market Y-o-Y Growth Rate by End User
3.9 North America Bispecific Antibody Market Share Comparison (2013-2029)
3.9.1 North America Bispecific Antibody Market Share by Region
3.9.2 North America Bispecific Antibody Market Share by Product Type
3.9.3 North America Bispecific Antibody Market Share by End User

Chapter 4 Europe Bispecific Antibody Market Overview

4.1 Europe Bispecific Antibody Market by Product Type
4.1.1 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Bispecific Antibody Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Bispecific Antibody Market by End User
4.2.1 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Bispecific Antibody Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Bispecific Antibody Market by Region
4.3.1 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Bispecific Antibody Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Bispecific Antibody Market Outlook (2013-2029)
4.4.1 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Bispecific Antibody Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Bispecific Antibody Market Y-o-Y Growth Rate by Region
4.8.2 Europe Bispecific Antibody Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Bispecific Antibody Market Y-o-Y Growth Rate by End User
4.9 Europe Bispecific Antibody Market Share Comparison (2013-2029)
4.9.1 Europe Bispecific Antibody Market Share by Region
4.9.2 Europe Bispecific Antibody Market Share by Product Type
4.9.3 Europe Bispecific Antibody Market Share by End User

Chapter 5 Asia Pacific Bispecific Antibody Market Overview

5.1 Asia Pacific Bispecific Antibody Market by Product Type
5.1.1 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Bispecific Antibody Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Bispecific Antibody Market by End User
5.2.1 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Bispecific Antibody Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Bispecific Antibody Market by Region
5.3.1 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Bispecific Antibody Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Bispecific Antibody Market Outlook (2013-2029)
5.4.1 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Bispecific Antibody Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Bispecific Antibody Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Bispecific Antibody Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Bispecific Antibody Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Bispecific Antibody Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Bispecific Antibody Market Share by Region
5.9.2 Asia Pacific Bispecific Antibody Market Share by Product Type
5.9.3 Asia Pacific Bispecific Antibody Market Share by End User

Chapter 6 South America Bispecific Antibody Market Overview

6.1 South America Bispecific Antibody Market by Product Type
6.1.1 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Bispecific Antibody Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Bispecific Antibody Market by End User
6.2.1 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Bispecific Antibody Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Bispecific Antibody Market by Region
6.3.1 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Bispecific Antibody Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Bispecific Antibody Market Outlook (2013-2029)
6.4.1 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Bispecific Antibody Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Bispecific Antibody Market Y-o-Y Growth Rate by Region
6.8.2 South America Bispecific Antibody Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Bispecific Antibody Market Y-o-Y Growth Rate by End User
6.9 South America Bispecific Antibody Market Share Comparison 2013-2029
6.9.1 South America Bispecific Antibody Market Share by Region
6.9.2 South America Bispecific Antibody Market Share by Product Type
6.9.3 South America Bispecific Antibody Market Share by End User

Chapter 7 MEA Bispecific Antibody Market Overview

7.1 MEA Bispecific Antibody Market by Product Type
7.1.1 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Bispecific Antibody Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Bispecific Antibody Market by End User
7.2.1 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Bispecific Antibody Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Bispecific Antibody Market by Region
7.3.1 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Bispecific Antibody Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Bispecific Antibody Market Outlook (2013-2029)
7.4.1 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Bispecific Antibody Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Bispecific Antibody Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Bispecific Antibody Market Y-o-Y Growth Rate by Region
7.8.2 MEA Bispecific Antibody Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Bispecific Antibody Market Y-o-Y Growth Rate by End User
7.9 MEA Bispecific Antibody Market Share Comparison (2013-2029)
7.9.1 MEA Bispecific Antibody Market Share by Region
7.9.2 MEA Bispecific Antibody Market Share by Product Type
7.9.3 MEA Bispecific Antibody Market Share by End User

Chapter 8 Global Bispecific Antibody Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included:
Ablynx (Belgium)
Adimab (United States)
Affimed Therapeutics (Germany)
Amgen (United States)
AstraZeneca (MedImmune) (United States)
Chugai Pharmaceutical (Japan)
Eli Lilly (United States)
EMD Serono (United States)
Neovii Biotech (Germany)
NovImmune SA (Switzerland)
Roche (Switzerland)
Sanofi (France)
Emergent BioSolutions (United States)
Genentech (United States)
MacroGenics (United States)
Merus (Netherlands)

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

Licensing Options

One User
$3900
Enterprise User
$7800